MSB 7.69% $1.19 mesoblast limited

DREAM HF Trial Video, page-24

  1. 12,206 Posts.
    lightbulb Created with Sketch. 1085
    The Phase 3 trial results will be considered pivotal to support regulatory approval in the United States, as well as in China through a partnership with Tasly Pharmaceuticals to develop and commercialize the product for advanced chronic heart failure.

    Mesoblast Website

    The Chinese market fairly sizeable .


    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.